Related Experiment Video
Updated: Jun 16, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Incorporating genetic potential when evaluating stature in children with cystic fibrosis
Zhumin Zhang1, Suzanne M Shoff, Huichuan J Lai
1Department of Nutritional Sciences, University of Wisconsin, Madison, Wisconsin, United States.
Insights
Adjusting for genetic potential is crucial for accurately assessing short stature in children with cystic fibrosis (CF). Failure to do so underestimates prevalence and biases lung function correlations.
Area of Science:
- Pediatric endocrinology
- Genetics
- Pulmonology
Background:
- The Cystic Fibrosis Foundation (CFF) guidelines recommend adjusting for genetic potential when evaluating height in children with CF.
- Limited data currently support this recommendation.
- Accurate height assessment is vital for monitoring growth and health outcomes in pediatric CF patients.
Purpose of the Study:
- To compare different methods of classifying short stature in children with cystic fibrosis (CF).
- To evaluate the impact of adjusting for genetic potential on short stature prevalence and its association with lung function.
Main Methods:
- Analysis of data from 3306 children with CF and documented parental heights from the 1986-2005 CFF Patient Registry.
- Comparison of three classification methods: unadjusted height percentile <10th, Himes adjusted height percentile <10th, and unadjusted height below CFF target lower bound.
Main Results:
- Children with CF had lower height percentiles than their parents.
- Himes adjustment significantly altered height percentile classification, particularly in children with short or tall parents.
- Prevalence of short stature varied substantially based on the classification method used.
- Himes adjustment revealed a stronger positive association between height percentile and lung function (percent predicted FEV1).
Conclusions:
- Failure to adjust for genetic potential leads to underestimation of short stature prevalence in children with CF.
- Unadjusted height assessments can bias the observed relationship between height and lung function.
- Adjusting for genetic potential provides a more accurate evaluation of growth status in pediatric CF patients.
Objective:
The 2002 Cystic Fibrosis Foundation (CFF) practice guidelines recommend adjusting for genetic potential when evaluating height status in children with CF. However, there is paucity of data to support this recommendation. We compared three methods of classifying short stature: unadjusted height percentile <10th, Himes adjusted height percentile <10th, and unadjusted height below the CFF target height lower bound.
Patients And Methods:
Data from 3306 children with parental heights documented in the 1986-2005 CFF Patient Registry were analyzed.
Results:
Mean height percentile of CF children (33rd) was lower than their parents' (mothers' 53rd, fathers' 57th), and 80% of CF children were below the average of their parental height percentiles. In children with short parents, Himes adjusted height percentile was significantly higher than unadjusted height percentile (27th vs. 8th), whereas the opposite was found in children with tall parents (Himes adjusted at 18th vs. unadjusted at 49th). Consequently, the prevalence of short stature decreased from 52% to 22% in children with short parents and increased from 8% to 34% in children with tall parents after Himes adjustment. In children with discrepant classification on short stature before and after Himes adjustment, percent predicted forced expiratory volume in one second was negatively associated with unadjusted height percentile but positively associated with Himes adjusted height percentile. In children with short parents, the CFF method underestimated the prevalence of short stature (9%) compared to the Himes method (22%).
Conclusion:
Without adjustment of genetic potential, the prevalence of short stature is underestimated and the association between height and lung function is biased.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
08:03Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
Related Concept Videos
Nature and Nurture
Polygenic Traits
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Gene-Environment Interactions
What is Genetic Engineering?